A Study to Assess the Safety and Tolerability of Single and Multiple Ascending Doses of Oral RO7020531 in Chinese Healthy Participants.
Clinical trial NCT03530917 · COMPLETED
Trial details
- NCT number
- NCT03530917
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-15
- Primary completion
- 2019-05-15
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.